Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heme Arginate and Adenosine Induced Vasodilation
NCT00856817Phase 4Terminated
- Sponsor
- Radboud University Medical Center
- Start
- Mar 2009
- Countries
- 1
01
Overview
A Phase 4 trial of heme arginate in atherosclerotic cardiovascular disease (ASCVD), sponsored by Radboud University Medical Center. Started Mar 2009; status: terminated.
02
Drugs
heme arginate
03
Conditions
atherosclerotic cardiovascular disease (ASCVD)
Beyond the preview
Go deeper on NCT00856817.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00856817.